Zur Kurzanzeige

2003-05-02Zeitschriftenartikel DOI: 10.1186/1471-2334-3-7
Comparison of two DNA targets for the diagnosis of Toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes
dc.contributor.authorReischl, Udo
dc.contributor.authorBretagne, Stéphane
dc.contributor.authorKrüger, Dominique
dc.contributor.authorErnault, Pauline
dc.contributor.authorCosta, Jean-Marc
dc.date.accessioned2018-05-07T13:25:41Z
dc.date.available2018-05-07T13:25:41Z
dc.date.created2009-12-02
dc.date.issued2003-05-02none
dc.identifier.otherhttp://edoc.rki.de/oa/articles/retzRqdNBbiQ/PDF/238OPd3i6nM3M.pdf
dc.identifier.urihttp://edoc.rki.de/176904/493
dc.description.abstractBackground: Toxoplasmosis is an infectious disease caused by the parasitic protozoan Toxoplasma gondii. It is endemic worldwide and, depending on the geographic location, 15 to 85% of the human population are asymptomatically infected. Routine diagnosis is based on serology. The parasite has emerged as a major opportunistic pathogen for immunocompromised patients, in whom it can cause life-threatening disease. Moreover, when a pregnant woman develops a primary Toxoplasma gondii infection, the parasite may be transmitted to the fetus and cause serious damage. For these two subpopulations, a rapid and accurate diagnosis is required to initiate treatment. Serological diagnosis of active infection is unreliable because reactivation is not always accompanied by changes in antibody levels, and the presence of IgM does not necessarily indicate recent infection. Application of quantitative PCR has evolved as a sensitive, specific, and rapid method for the detection of Toxoplasma gondii DNA in amniotic fluid, blood, tissue samples, and cerebrospinal fluid. Methods: Two separate, real-time fluorescence PCR assays were designed and evaluated with clinical samples. The first, targeting the 35-fold repeated B1 gene, and a second, targeting a newly described multicopy genomic fragment of Toxoplasma gondii. Amplicons of different intragenic copies were analyzed for sequence heterogeneity. Results: Comparative LightCycler experiments were conducted with a dilution series of Toxoplasma gondii genomic DNA, 5 reference strains, and 51 Toxoplasma gondii-positive amniotic fluid samples revealing a 10 to 100-fold higher sensitivity for the PCR assay targeting the newly described 529-bp repeat element of Toxoplasma gondii. Conclusion: We have developed a quantitative LightCycler PCR protocol which offer rapid cycling with real-time, sequence-specific detection of amplicons. Results of quantitative PCR demonstrate that the 529-bp repeat element is repeated more than 300-fold in the genome of Toxoplasma gondii. Since individual intragenic copies of the target are conserved on sequence level, the high copy number leads to an ultimate level of analytical sensitivity in routine practice. This newly described 529-bp repeat element should be preferred to less repeated or more divergent target sequences in order to improve the sensitivity of PCR tests for the diagnosis of toxoplasmosis.eng
dc.language.isoeng
dc.publisherRobert Koch-Institut, Infektionskrankheiten / Erreger
dc.subjectAnimalseng
dc.subjectHumanseng
dc.subjectPolymerase Chain Reactioneng
dc.subjectSensitivity and Specificityeng
dc.subjectDNA Probeseng
dc.subjectFluorescence Resonance Energy Transfereng
dc.subjectNucleic Acid Hybridizationeng
dc.subjectToxoplasma/geneticseng
dc.subjectToxoplasma/isolation & purificationeng
dc.subjectToxoplasmosis/diagnosiseng
dc.subjectToxoplasmosis/microbiologyeng
dc.subject.ddc610 Medizin
dc.titleComparison of two DNA targets for the diagnosis of Toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes
dc.typeperiodicalPart
dc.identifier.urnurn:nbn:de:0257-1003047
dc.identifier.doi10.1186/1471-2334-3-7
dc.identifier.doihttp://dx.doi.org/10.25646/418
local.edoc.container-titleBMC Infectious Diseases
local.edoc.fp-subtypeArtikel
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttp://www.biomedcentral.com/1471-2334/3/7
local.edoc.container-publisher-nameBioMedCentral
local.edoc.container-volume3
local.edoc.container-issue7
local.edoc.container-year2003

Zur Kurzanzeige